from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3133c/devR

LFCtreatmentdescriptionclass of inhibitor

0.288

Amikacinug/mL Amikacintranslation

-0.231

Cap5-10ug/mL Capreomycintranslation

0.033

Rox10-50 ug/mL Roxithromycintranslation

0.270

SM2-5 ug/mL Streptomycintranslation

0.387

Tet5-10 ug/mL Tetracyclinetranslation

0.075

Rif0.2-5ug/mL Rifampicintranscription

0.548

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.021

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.026

CPZ10-50 ug/mL Chlorpromazinerespiration

2.656

Clofazimine10-13 ug/mL Clofaziminerespiration

1.505

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.557

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.001

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.929

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.972

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.291

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.796

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.097

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.444

Nigericin50 uM Nigericinrespiration

0.322

TRC10-150 ug/mL Triclosanrespiration

1.561

TRZ10-25 ug/mL Thioridazinerespiration

0.087

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.797

menadione6-10 ug/mL Menadionerespiration

0.205

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.028

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.069

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.115

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-3.206

NRP_1Non-replicating persistence stage 1dosRassociated

-0.225

Amp0.2mg/mL AmpicillincellWall

0.507

Cephalexin20-100 ug/mL CephalexincellWall

-0.141

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.250

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.261

EMB10-20 ug/mL EthambutolcellWall

-0.376

Eta12-40 ug/mL EthionamidecellWall

-0.505

INH0.2-0.4 ug/mL IsoniazidcellWall

0.003

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.278

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.409

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.248

BZA0.12 mg/mL BenzamidearomaticAmides

-0.517

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.364

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.335

H2O24 mM hydrogen peroxideDNAdamaging

-0.151

Levo10 ug/mL LevofloxacinDNAdamaging

-0.308

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.661

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.054

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.183

UVUV-irradiationDNAdamaging

0.896

ARP41-4 ug/mL Antitubercular compound ARP4?

0.274

Antimycin12.5-50 ug/mL Antimycin A?

-1.639

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.232

PA_110-50 ug/mL Antitubercular compound PA-1?

0.374

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.018

PA8240.2-2 ug/mL PA-824?

2.334

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.146

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.621

Verapamil50 uM Verapamil?

-1.014

mercaptoethanol2 mM 2-Mercaptoethanol?

0.818

methoxatin10-20 ug/mL Methoxatin?